MedTrace Logo

Improving Quality of Osteoporosis Care Through Patient Storytelling

NCT01112098 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2997

Last updated 2011-05-10

No results posted yet for this study

Summary

The purpose of this exploratory study is to test novel, mailed, low-cost, direct-to-patient intervention materials (i.e., a personalized letter and osteoporosis information pamphlet) designed to increase rates of dual energy X-ray absorptiometry (DXA) utilization and improve osteoporosis quality of care.

Conditions

Interventions

BEHAVIORAL

Patient Pamphlet

letter informs patient of opportunity to self-schedule a DXA scan; pamphlet includes information about receiving a DXA scan

Sponsors & Collaborators

  • Procter and Gamble

    collaborator INDUSTRY

  • University of Alabama at Birmingham

    lead OTHER

Principal Investigators

  • Jeffrey R Curtis, MD, MPH, MS · University of Alabama at Birmingham

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2010-12-31
Completion
2011-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01112098 on ClinicalTrials.gov